Contact Us
Genital Warts Global Market Report 2025
Global Genital Warts Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Genital Warts Global Market Report 2025

By Drug Type (Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid), By Treatment (Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments), By Gender (Female, Male), By End Users (Hospitals, Clinics, Home Care Settings) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Genital Warts Market Overview

• Genital Warts market size has reached to $1.97 billion in 2024

• Expected to grow to $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%

• Growth Driver: Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts Market

• Market Trend: Innovative Dermatology Drugs For Genital Warts

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Genital Warts Market?

Genital warts refer to condylomata acuminata, which are sexually transmitted infections (STI) caused by certain strains of the human papillomavirus (HPV). These warts typically appear as small growths or clusters of bumps on or around the genital and anal areas and vary in size and shape, may be raised or flat, and often have a cauliflower-like appearance. Genital warts are usually painless but can cause itching, discomfort, or bleeding during sexual intercourse.

The main types of drugs for genital warts are imiquimod, podophyllin, podofilox, and trichloroacetic acid. Imiquimod refers to a topical cream that stimulates the immune system to fight genital warts caused by HPV. The different treatments include chemical treatment, ablative treatment, preventive treatment, and other treatments. The genders include females and males and are used by different end users, such as hospitals, clinics, and home care settings.

Genital Warts Market Size and growth rate 2025 to 2029: Graph

What Is The Genital Warts Market Size 2025 And Growth Rate?

The genital warts market size has grown strongly in recent years. It will grow from $1.97 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to the focus on patient-centered care, growing emphasis on early detection and treatment, increasing availability of therapies developed for self-target applications, and the increase in clinical trials and recurrence of genital warts.

What Is The Genital Warts Market Growth Forecast?

The genital warts market size is expected to see strong growth in the next few years. It will grow to $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to the adoption of telemedicine and digital health platforms for remote consultation and treatment monitoring, growing demand for effective and affordable treatments for STIs, the emerging popularity of loop electrosurgical excision procedures, the escalating demand for interferon alfa-n3 injection and increasing availability of therapies. Major trends in the forecast period include advancements in diagnostic technologies, a shift towards combination therapies, expansion of telehealth and online consultations, emergence of novel therapeutic targets, and expansion in emerging markets.

The forecast of 5.1% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of cryotherapy devices and imiquimod cream sourced from Canada and Switzerland, thereby reducing treatment efficacy for Human Papillomavirus(HPV)-related lesions and elevating dermatology clinic expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Genital Warts Market Segmented?

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid

2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments

3) By Gender: Female, Male

4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegmments

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

What Is Driving The Genital Warts Market? Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts Market

The increasing prevalence of sexually transmitted infections (STIs) propels the growth of the genital warts market going forward. Sexually transmitted infections (STIs) are infections that are primarily transmitted through sexual contact, including vaginal, anal, and oral sex, and are caused by bacteria, viruses, or parasites. The prevalence of sexually transmitted infections is growing due to increased sexual activity, inadequate use of protection, and limited access to education and healthcare services. Genital warts are a common sexually transmitted infection (STI) caused by specific strains of the human papillomavirus (HPV). They spread through direct skin-to-skin contact during sexual activity. For instance, in October 2023, according to the Joint United Nations Programme on HIV/AIDS, a Switzerland-based, comprehensive global program to prevent HIV infection, in 2021, around 38.7 million people were infected with HIV, which increased to 39.0 million people in 2022, with 1.3 million newly infected people in the year 2022. Therefore, the increasing prevalence of sexually transmitted infections (STIs) is driving the growth of the genital warts industry.

Who Are The Major Players In The Global Genital Warts Market?

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

What Are The Key Trends Of The Global Genital Warts Market? Innovative Dermatology Drugs For Genital Warts

Major companies operating in the genital warts market are developing novel treatment options, such as novel dermatology drugs, to address the challenges faced by patients with genital warts. Dermatology drugs refer to newly developed pharmaceuticals or therapeutic agents specifically designed to treat various dermatologic conditions, such as genital warts. For instance, in March 2023, Verrica Pharmaceuticals Inc., a US-based dermatology pharmaceutical company, received New Chemical Entity (NCE) status for its drug candidate YCANTH. YCANTH is being developed to treat genital warts and has completed phase 2 trials. With FDA NCE status, the company now has at least five years of protection from generic competition.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Genital Warts Market? Endo, Inc. Acquires Endo International Plc To Bolster Generic And Specialty Pharmaceutical Offerings

In April 2024, Endo, Inc., a US-based generics and specialty-branded pharmaceutical company, acquired Endo International plc for an undisclosed amount. Through this acquisition, Endo, Inc. aims to strengthen its portfolio of both generic and specialty pharmaceuticals, enhancing its capacity to serve patients and healthcare providers. Endo International plc, a US-based generics and specialty-branded pharmaceutical company.

What Is The Regional Outlook For The Global Genital Warts Market?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genital Warts Market?

The genital warts market consists of revenues earned by entities by providing services such as medical consultations, diagnostic testing, treatment procedures, follow-up care, and patient education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The genital warts market also includes sales of topical treatments, cryotherapy devices, surgical instruments, immune response modifiers, and antiviral medications. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Genital Warts Industry?

The genital warts market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genital warts industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Genital Warts Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.06 billion
Revenue Forecast In 2034 $2.52 billion
Growth Rate CAGR of 5.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid
2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments
3) By Gender: Female, Male
4) By End Users: Hospitals, Clinics, Home Care Settings Subsegmments 1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%
2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%
3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%
4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Genital Warts Market Characteristics

3. Genital Warts Market Trends And Strategies

4. Genital Warts Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Genital Warts Growth Analysis And Strategic Analysis Framework

5.1. Global Genital Warts PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Genital Warts Market Growth Rate Analysis

5.4. Global Genital Warts Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Genital Warts Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Genital Warts Total Addressable Market (TAM)

6. Genital Warts Market Segmentation

6.1. Global Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Imiquimod

Podophyllin

Podofilox

Trichloroacetic Acid

6.2. Global Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemical Treatment

Ablative Treatment

Preventive Treatment

Other Treatments

6.3. Global Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Female

Male

6.4. Global Genital Warts Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Home Care Settings

6.5. Global Genital Warts Market, Sub-Segmentation Of Imiquimod, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Imiquimod Cream 5%

Imiquimod Cream 3.75%

6.6. Global Genital Warts Market, Sub-Segmentation Of Podophyllin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Podophyllin Resin 10%

Podophyllin Resin 25%

6.7. Global Genital Warts Market, Sub-Segmentation Of Podofilox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Podofilox Gel 0.5%

Podofilox Solution 0.5%

6.8. Global Genital Warts Market, Sub-Segmentation Of Trichloroacetic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Trichloroacetic Acid 80-90%

Trichloroacetic Acid 50-70%

7. Genital Warts Market Regional And Country Analysis

7.1. Global Genital Warts Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Genital Warts Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genital Warts Market

8.1. Asia-Pacific Genital Warts Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genital Warts Market

9.1. China Genital Warts Market Overview

9.2. China Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genital Warts Market

10.1. India Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genital Warts Market

11.1. Japan Genital Warts Market Overview

11.2. Japan Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genital Warts Market

12.1. Australia Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genital Warts Market

13.1. Indonesia Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genital Warts Market

14.1. South Korea Genital Warts Market Overview

14.2. South Korea Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genital Warts Market

15.1. Western Europe Genital Warts Market Overview

15.2. Western Europe Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genital Warts Market

16.1. UK Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genital Warts Market

17.1. Germany Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genital Warts Market

18.1. France Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genital Warts Market

19.1. Italy Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genital Warts Market

20.1. Spain Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genital Warts Market

21.1. Eastern Europe Genital Warts Market Overview

21.2. Eastern Europe Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genital Warts Market

22.1. Russia Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genital Warts Market

23.1. North America Genital Warts Market Overview

23.2. North America Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genital Warts Market

24.1. USA Genital Warts Market Overview

24.2. USA Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genital Warts Market

25.1. Canada Genital Warts Market Overview

25.2. Canada Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genital Warts Market

26.1. South America Genital Warts Market Overview

26.2. South America Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genital Warts Market

27.1. Brazil Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genital Warts Market

28.1. Middle East Genital Warts Market Overview

28.2. Middle East Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genital Warts Market

29.1. Africa Genital Warts Market Overview

29.2. Africa Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genital Warts Market Competitive Landscape And Company Profiles

30.1. Genital Warts Market Competitive Landscape

30.2. Genital Warts Market Company Profiles

30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis

31. Genital Warts Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.

31.2. Bausch Health Companies Inc.

31.3. Sun Pharmaceuticals

31.4. Perrigo Company plc

31.5. Glenmark Pharmaceutical Inc.

31.6. Taro Pharmaceutical Industries Ltd.

31.7. Serum Institute of India Pvt. Ltd.

31.8. ANI Pharmaceuticals Inc.

31.9. Ligand Pharmaceuticals Incorporated

31.10. Orgenesis Inc.

31.11. Verrica Pharmaceuticals Inc.

31.12. CryoConcepts LP

31.13. CryoIQ Global AB

31.14. Cassiopea Inc.

31.15. Aresus Pharma Inc.

32. Global Genital Warts Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genital Warts Market

34. Recent Developments In The Genital Warts Market

35. Genital Warts Market High Potential Countries, Segments and Strategies

35.1 Genital Warts Market In 2029 - Countries Offering Most New Opportunities

35.2 Genital Warts Market In 2029 - Segments Offering Most New Opportunities

35.3 Genital Warts Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Genital Warts Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Genital Warts Market, Sub-Segmentation Of Imiquimod, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Genital Warts Market, Sub-Segmentation Of Podophyllin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Genital Warts Market, Sub-Segmentation Of Podofilox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Genital Warts Market, Sub-Segmentation Of Trichloroacetic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Genital Warts Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Genital Warts Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Merck & Co. Inc. Financial Performance
  • Table 80: AbbVie Inc. Financial Performance
  • Table 81: Sanofi S.A. Financial Performance
  • Table 82: Novartis AG Financial Performance
  • Table 83: 3M Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Genital Warts Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Genital Warts Market, Sub-Segmentation Of Imiquimod, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Genital Warts Market, Sub-Segmentation Of Podophyllin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Genital Warts Market, Sub-Segmentation Of Podofilox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Genital Warts Market, Sub-Segmentation Of Trichloroacetic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Genital Warts Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Genital Warts Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Merck & Co. Inc. Financial Performance
  • Figure 80: AbbVie Inc. Financial Performance
  • Figure 81: Sanofi S.A. Financial Performance
  • Figure 82: Novartis AG Financial Performance
  • Figure 83: 3M Company Financial Performance

Frequently Asked Questions

Genital warts refer to condylomata acuminata, which are sexually transmitted infections (STI) caused by certain strains of the human papillomavirus (HPV). These warts typically appear as small growths or clusters of bumps on or around the genital and anal areas and vary in size and shape, may be raised or flat, and often have a cauliflower-like appearance. Genital warts are usually painless but can cause itching, discomfort, or bleeding during sexual intercourse. For further insights on this market, request a sample here

The market major growth driver - Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts Market. For further insights on this market, request a sample here

The genital warts market size has grown steadily in recent years. It will grow from $1.97 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to the focus on patient-centered care, growing emphasis on early detection and treatment, increasing availability of therapies developed for self-target applications, and the increase in clinical trials and recurrence of genital warts. The genital warts market size is expected to see strong growth in the next few years. It will grow to " $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to the adoption of telemedicine and digital health platforms for remote consultation and treatment monitoring, growing demand for effective and affordable treatments for STIs, the emerging popularity of loop electrosurgical excision procedures, the escalating demand for interferon alfa-n3 injection and increasing availability of therapies. Major trends in the forecast period include advancements in diagnostic technologies, a shift towards combination therapies, expansion of telehealth and online consultations, emergence of novel therapeutic targets, and expansion in emerging markets. For further insights on this market, request a sample here

The genital wartsmarket covered in this report is segmented –
1) By Drug Type: Imiquimod; Podophyllin; Podofilox; Trichloroacetic Acid
2) By Treatment: Chemical Treatment; Ablative Treatment; Preventive Treatment; Other Treatments
3) By Gender: Female; Male
4) By End Users: Hospitals; Clinics; Home Care Settings Subsegments:
1) By Imiquimod: Imiquimod Cream 5%; Imiquimod Cream 3.75%
2) By Podophyllin: Podophyllin Resin 10%; Podophyllin Resin 25%
3) By Podofilox: Podofilox Gel 0.5%; Podofilox Solution 0.5%
4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%; Trichloroacetic Acid 50-70% For further insights on this market,
request a sample here

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Dermatology Drugs For Genital Warts. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon